1. 126OOlaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial. (24th November 2019) Authors: Oh, D-Y; Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M J; Park, J Oh; Hochhauser, D; Arnold, D; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E M; McGuinness, D; Cui, K Y; Schlienger, K; Locker, G Y; Kindler, H L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗